Current practice in novel drugs of Myeloma in Germany.
Hartmut Goldschmidt is Professor of Medicine (Hematology and Oncology) and Head of the Multiple Myeloma Program University Hospital Heidelberg, Germany.
Foredrag på Fagsamling om myelomatose i Oslo 23. oktober 2023
Негізгі бет Current practice in novel drugs of Myeloma in Germany. Hartmut Goldschmidt
Пікірлер